Cellanome

Cellanome is a biotechnology company based in Palo Alto, California, founded in 2020. The company focuses on developing an automated platform for cellular analysis, which enables researchers to conduct iterative live cell phenotypic and functional assays. This platform allows for the observation of individual cell behaviors and interactions over time, providing insights into cellular responses under various conditions. The automated platform supports flexibility and integration into existing cell biology workflows, accommodating a wide range of cell types. It also facilitates combinatorial assays without the need for switching platforms or consuming additional samples, enhancing research efficiency. Cellanome has raised $213.75 million in funding, reflecting strong investor confidence in its innovative approach to cellular analysis. The company is committed to advancing biotechnology and offers career opportunities for skilled individuals passionate about engineering and scientific innovation.